Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1–14 Years with Chronic Gastric Acid-Related Disease-Reference-Cited by-同舟云学术

Efficacy and Safety of Long-Term Administration of Esomeprazole in Japanese Pediatric Patients Aged 1–14 Years with Chronic Gastric Acid-Related Disease

Published:2024 Issue:5 Volume:27 Page:274
ISSN:2234-8646
Container-title:Pediatric Gastroenterology, Hepatology & Nutrition
language:en
Short-container-title:Pediatr Gastroenterol Hepatol Nutr

Author:

Mori Masaaki¹^ORCID,Nakayama Yoshiko²^ORCID,Nishimata Shigeo³^ORCID,Yokoyama Tadafumi⁴^ORCID,Matsuoka Ryo⁵^ORCID,Hatori Reiko⁶^ORCID,Shimizu Masaki⁷^ORCID,Arai Katsuhiro⁸^ORCID,Etani Yuri⁹^ORCID,Sogo Tsuyoshi¹⁰^ORCID,Ishizu Tomoko¹¹^ORCID,Nii Masahiro¹²^ORCID,Nakashima Ryosuke¹²^ORCID,Shimizu Toshiaki¹³^ORCID

Affiliation:

1. Department of Lifetime Clinical Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

2. School of Health Science, Shinshu University School of Medicine, Matsumoto, Japan.

3. Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

4. Department of Pediatrics, Kanazawa University, Kanazawa, Japan.

5. Department of Pediatrics, Fuji City General Hospital, Shizuoka, Japan.

6. Center of Regional Medical Research and Education, Gunma University Hospital, Maebashi, Japan.

7. Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

8. Division of Gastroenterology, National Center for Child Health and Development, Tokyo, Japan.

9. Department of Pediatric Gastroenterology, Nutrition and Endocrinology, Osaka Women’s and Children’s Hospital, Osaka, Japan.

10. Department of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohama City Tobu Hospital, Yokohama, Kanagawa, Japan.

11. Research and Development, AstraZeneca, Tokyo, Japan.

12. Research and Development, AstraZeneca, Osaka, Japan.

13. Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Funder

AstraZeneca KK

Publisher

XMLink

Link

https://pghn.org/pdf/10.5223/pghn.2024.27.5.274

Reference15 articles.

1. Acid peptic diseases: pharmacological approach to treatment

2. Inverse time trends of peptic ulcer and reflux esophagitis show significant association with reduced prevalence of Helicobacter pylori infection

3. Trends in gastroesophageal reflux disease in Japanese children and adolescents

4. Low‐dose aspirin‐induced gastric mucosal injury after Fontan surgery in an adolescent

5. Ministry of Health, Labour and Welfare of Japan (MHLW). Pharmaceuticals and medical devices safety information [Internet]. Tokyo. MHLW. 2011. cited 2024 June 6. Available from: https://www.pmda.go.jp/files/000153067.pdf